{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:54:14Z","timestamp":1777859654401,"version":"3.51.4"},"reference-count":53,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:00:00Z","timestamp":1335484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p>Due to relatively recent and ongoing world events (eg, terrorist attacks, wars, and natural disasters), there has been a shift in attention from some of the more common psychiatric illnesses to one of the more elusive, namely, posttraumatic stress disorder (PTSD). PTSD is a severe, and often chronic, condition that can lead to significant morbidity and mortality. Although originally a condition seen primarily among war veterans, PTSD is now becoming more prevalent in the general community. PTSD often presents concurrently with other conditions, such as depression, bipolar, anxiety\/panic disorders, and alcohol and drug abuse. Because of this, PTSD often goes unrecognized and is underdiagnosed in clinical practice. Thus, an opportunity for pharmacist intervention exists, both in the institution and in the community. With proper education and training, pharmacists can be efficient in screening for signs and symptoms of PTSD, triaging appropriate patients, and can play an integral role in managing the diverse array of drug therapy options for PTSD.<\/jats:p>","DOI":"10.1177\/0897190012442714","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T20:15:59Z","timestamp":1335644159000},"page":"541-551","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Pharmacotherapeutic Approach to the Management of Chronic Posttraumatic Stress Disorder"],"prefix":"10.1177","volume":"25","author":[{"given":"Adam Michael","family":"Spaulding","sequence":"first","affiliation":[{"name":"Albany College of Pharmacy and Health Sciences, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.2.115"},{"key":"e_1_3_2_3_2","unstructured":"Brady KT. Gender differences in PTSD. Medscape website. 2001. http:\/\/www.medscape.org\/viewarticle\/418733"},{"key":"e_1_3_2_4_2","first-page":"1179","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"Dipiro JT","year":"2008","unstructured":"Dipiro JT, Talbert RL, Yee GC, Pharmacotherapy: A Pathophysiologic Approach. 7th ed. McGraw Hill: New York, NY; 2008:1179\u20131188.","edition":"7"},{"issue":"11","key":"e_1_3_2_5_2","first-page":"31","article-title":"A review of pharmacotherapy for PTSD","volume":"31","author":"Chavez B","year":"2006","unstructured":"Chavez B. A review of pharmacotherapy for PTSD. US Pharm. 2006;31(11):31\u201338.","journal-title":"US Pharm"},{"key":"e_1_3_2_6_2","volume-title":"Management of Traumatic Stress Disorder and Acute Stress Reaction: Clinical Practice Guideline","author":"Veterans Affairs\/Department of Defense","year":"2011","unstructured":"Veterans Affairs\/Department of Defense. Management of Traumatic Stress Disorder and Acute Stress Reaction: Clinical Practice Guideline. Washington, DC: Veterans Affairs\/Department of Defense; 2011."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_3_2_8_2","volume-title":"Guideline watch (March 2009): Practice Guideline for the treatment of patients with Acute Stress Disorder and Posttraumatic Stress Disorder","author":"American Psychiatric Association","year":"2009","unstructured":"American Psychiatric Association. Guideline watch (March 2009): Practice Guideline for the treatment of patients with Acute Stress Disorder and Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Association; 2009."},{"key":"e_1_3_2_9_2","volume-title":"Treatment of PTSD: An Assessment of the Evidence","author":"Institute of Medicine","year":"2007","unstructured":"Institute of Medicine: Treatment of PTSD: An Assessment of the Evidence. Washington, DC: National Academies Press. http:\/\/www.iom.edu\/?id=47402, 2007."},{"issue":"1","key":"e_1_3_2_10_2","first-page":"29","article-title":"Risk and resilience in posttraumatic stress disorder","volume":"65","author":"Yehuda R","year":"2004","unstructured":"Yehuda R. Risk and resilience in posttraumatic stress disorder. J Clin Psychiatry. 2004;65(suppl 1):29\u201336.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_3_2_11_2","first-page":"24","article-title":"The psychobiology of posttraumatic stress disorder","volume":"61","author":"Nutt DJ","year":"2000","unstructured":"Nutt DJ. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 2000;61(suppl 1):24\u201329.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01672-4"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhp022"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(03)00047-8"},{"issue":"4","key":"e_1_3_2_15_2","first-page":"274","article-title":"Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation","volume":"4","author":"Chambers RA","year":"1999","unstructured":"Chambers RA, Bremner JD, Moghaddam B, Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry. 1999;4(4):274\u2013281.","journal-title":"Semin Clin Neuropsychiatry"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007802031411"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-04-1507"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.63.6.928"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.14.1837"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.485"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.10.1829"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11020321"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.1082"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0105"},{"issue":"3","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.64719\/pb.4179","article-title":"Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo","volume":"37","author":"Tucker P","year":"2003","unstructured":"Tucker P, Potter-Kimball R, Wyatt DB, Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacology Bull. 2003;37(3):135\u2013149.","journal-title":"Psychopharmacology Bull"},{"issue":"2","key":"e_1_3_2_26_2","first-page":"166","article-title":"Failed efficacy of fluoxetine in the treatment of post-traumatic stress disorder: results of a fixed-dose, placebo-controlled study","volume":"27","author":"Martenyi F","year":"2007","unstructured":"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of post-traumatic stress disorder: results of a fixed-dose, placebo-controlled study. JCP. 2007;27(2):166\u2013170.","journal-title":"JCP"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.5.519"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-6163.2002.tb00665.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000222514.71390.c1"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01411-7"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2005.01447.x"},{"issue":"4","key":"e_1_3_2_32_2","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"67","author":"Boer TD","year":"1996","unstructured":"Boer TD. The pharmacologic profile of mirtazapine. J Clin Psych. 1996;67(supp 4):19\u201325.","journal-title":"J Clin Psych"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.20008"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199106000-00011"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.7.1024"},{"key":"e_1_3_2_36_2","first-page":"185","article-title":"Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features","volume":"21","author":"Pivac N","year":"2006","unstructured":"Pivac N, Kozaric-Kovacic D. Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features. Croat Med J. 2006;21:185\u2013187.","journal-title":"Croat Med J"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200302000-00003"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000182116.49887.ae"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32825ea324"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1080"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401230109148960"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0104"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00011-6"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31802e5115"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(86)72590-5"},{"issue":"9","key":"e_1_3_2_46_2","first-page":"361","article-title":"Valproate in combat-related posttraumatic stress disorder","volume":"52","author":"Fesler FA","year":"1991","unstructured":"Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin psychiatry. 1991;52(9):361\u2013364.","journal-title":"J Clin psychiatry"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318160f83b"},{"issue":"2","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/104012370902100205","article-title":"A preliminary controlled trial of divalproex in posttraumatic stress disorder","volume":"21","author":"Hamner MB","year":"2009","unstructured":"Hamner MB, Faldowski RA, Robert S, A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009;21(2):89\u201394.","journal-title":"Ann Clin Psychiatry"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.06.032"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.07.001"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.09.023"},{"issue":"9","key":"e_1_3_2_52_2","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: a prospective study","volume":"57","author":"Gelphin E","year":"1996","unstructured":"Gelphin E, Bonne O, Peri T, Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57(9):390\u2013394.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-011-9494-1"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.3.369"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190012442714","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190012442714","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190012442714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:35:09Z","timestamp":1777509309000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190012442714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1177\/0897190012442714"],"URL":"https:\/\/doi.org\/10.1177\/0897190012442714","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]}}}